As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical TestingAugust 22, 2012 10:20 am | by Bio-Medicine.Org | News | Comments
ROCKVILLE, Md. and SEATTLE, Aug. 22, 2012 /PRNewswire-USNewswire/ -- Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate, ID93 + GLA-SE. The Phase I clinical trial will assess the safety, tolerability and immunogenicity of the vaccine candidate in 60 healthy adult volunteers. The study...
Medical Alarm Concepts Begins Shipments To Europe - Company Ordering Additional Inventory To Keep Up With Growing DemandAugust 22, 2012 9:51 am | by Bio-Medicine.Org | News | Comments
KING OF PRUSSIA, Pa., Aug. 22, 2012 /- Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK), manufacturer of the MediPendant™ two-way voice personal medical alarm, today announced it has begun the process of shipping product to its new Northern European customer. This initial order, which was announced on June 20, 2012, is for 500 units, with additional orders expected...
ROCHESTER, N.Y., Aug. 22, 2012 /- Caliber Imaging & Diagnostics, formerly Lucid, Inc. (OTC Bulletin Board: LCDX ), the leader in Rapid Cell Imaging and Diagnostics technology, today announced the release of two next-generation products in its FDA-cleared VivaScope ® family. The new VivaScope 1500 and VivaScope 3000 produce high-quality images of living cells at...
PARAMUS, N.J.--(BUSINESS WIRE)--Aug 22, 2012--Proteonomix, Inc. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of...
The declining rate of infant circumcisions may translate to billions in extra healthcare costs due for sexually transmitted infections and related cancers. MASSDEVICE ON CALL — If U.S. infant circumcision levels drop to those seen in Europe, the subsequent increase in sexually transmitted infections and related cancers could cost the healthcare system billions, according to researchers. The decline over the past 20 years has already cost more than $20 billion according to disease experts and health economists at Johns Hopkins. News Well, On Call, Pediatricsread more
A neurosurgeon at InVivo Therapeutics Holdings Corp. has been given a $10,000 MDH Research Award for a project to reduce scarring of the spinal cord following surgery using a drug-releasing, injectable biomaterial.
There is a potential risk that the pump module door keypad overlay may separate from the keypad assembly. This product may cause serious adverse health consequences, including death.
Immunogen Inc. (Nasdaq: IMGN) saw its stock rise almost 4 percent Wednesday, after an analyst at New York investment bank Cowen and Co. launched coverage of the stock with an “outperform” or “buy” rating.
EMD Millpore of Billerica will acquire Biochrom AG located in Berlin, Germany for an undisclosed value in a transaction expected to be completed during the fourth quarter of 2012.
Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) announced the results of pre-clinical studies today using its RNA interference (RNAi) technology which it says could lead to the development of more effective vaccine therapies for cancer as well as infectious diseases.
The Centers for Medicare & Medicaid request nominations for the 42 open seats on the Medicare Evidence Development & Coverage Advisory Committee. The Centers for Medicare & Medicaid are looking for nominees to fill the 42 expiring memberships on the Medicare Evidence Development & Coverage Advisory Committee, according to an agency notice. The agency needs both voting and non-voting members to fill seats expiring January 2013, and is asking for nominations for 2-year terms. News Well, Medicareread more
Congressman and White House hopeful Ron Paul's (R-Texas) new bill aims to give doctors the authority to authorize treatment with unapproved medical devices for patients who are terminally ill. House Republican and White House hopeful Ron Paul (R-Texas) aims to give doctors increased authority to prescribe terminal patients treatment with unapproved medical devices. Paul's bill, introduced this month and dubbed the "Compassionate Freedom Choice Act of 2012," would allow physicians the ability to treat terminally ill patients with investigational devices as a last resort. News Well, Capitol Hill, Food & Drug Administration (FDA), Investigational Device Exemption (IDE)read more
Newly acquired Synthes recalls its Hemostatic Bone Putty over concerns that the product may "ignite" if it comes into contact with certain surgical devices. Newly acquired Synthes Inc. recalled certain lots of its Hemostatic Bone Putty over concerns that the product may catch on fire in certain conditions. The product, which is used to stop bone bleeding by establishing a physical barrier along the edges of bones, should be returned to Synthes, according to the FDA notice. News Well, Recalls, Resorbable bone materialsread more
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it has expanded its intellectual property portfolio in medical robotics with the issuance of 30 additional U.S. patents since January 2011. Hansen Medical also shares rights to more than 250...
Fluidigm announces exercise of underwriters over-allotment option and closing of $60 million public offering of common stockAugust 21, 2012 3:44 pm | by I-Micronews | News | Comments
Fluidigm Corporation a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries announces that it has closed the previously announced underwritten public offering of 4,209,000 shares of its common stock at a price to the public of $14.25 per share for gross proceeds of approximately $60 million.